Bristol-Myers Squibb Company | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (117)

Latest Posts

About This Stock More About This Stock
3 Blue Chip Dividend Stocks To Play Defense
Article By: Dividend Power
Friday, February 2, 2024 9:15 PM EST
We will discuss 3 long-term blue chip stocks to play defense. They have raised their dividends each year for over ten years, have current yields above the S&P 500 Index average, and should continue to increase their dividends for years to come
In this article: BMY, EMR, QCOM
Read
BMY Stock Dividend Delight: A Blue-Chip’s Healthy Yield
Article By: Tactical Investor
Wednesday, January 31, 2024 7:20 PM EST
In the grand theater of the financial markets, Bristol-Myers Squibb stands out as a robust performer. Despite the recent pullback, the market sentiment towards this biopharmaceutical titan remains buoyant
In this article: BMY
Read
Bullish Continuation In '24? 3 Market Areas To Watch
Article By: Zacks Investment Research
Wednesday, January 10, 2024 11:00 PM EST
This article discusses 3 market areas that should outperform dramatically over the next 12 months...
In this article: BMY, NVO, NVS, CYTK, IBB, MSFT, NVDA, IWM, META, GOOGL, KRTX
Read
After A Bruising 2023, Bristol-Myers Squibb Forges A Risky M&A Strategy
Article By: Invezz
Wednesday, December 27, 2023 4:33 AM EST
Bristol-Myers Squibb was one of the worst performers in the S&P 500 in 2023. BMY has now focused on growth through acquisitions, a high-risk strategy.
In this article: BMY
Read
Bristol-Myers Buying Karuna Signals A Biotech Boom Ahead: Jefferies
Article By: Invezz
Sunday, December 24, 2023 3:43 PM EST
Bristol-Myers Squibb is buying Karuna Therapeutics for $14 billion. Karuna Therapeutics Inc stock jumped nearly 50% on Friday. Jefferies analyst Michael Yee shares his view on biotech stocks.
In this article: BMY, KRTX
Read

Latest Tweets for $BMY

No tweets yet!

PARTNER HEADLINES

$BMY

Macy’s Q1 Was Bad, But The Company Has The Cash To Survive The Current Pandemic
Jonathan Weber 7/3/2020 4:06:07 PM

Glad you liked it Sheryl! Right now I think a range of REITs and healthcare stocks are attractive from a risk-reward standpoint, including $ABBV, $BMY, $O, $SLG, $SPG, etc.

Bristol-Meyers (BMY) Head And Shoulders Pattern
Flat Broke 2/26/2020 8:46:50 PM

I fear bad news is acoming for $BMY.

Bristol-Myers To Buy Celgene; A $74 Billion Deal
Kalara J. Curtis 5/22/2019 10:47:49 AM

Nice info, thanks for sharing with us. Bullish on $BMY

OncoSec Raising Its Profile In Fight Against Cancer
Dick Kaplan 9/6/2017 4:03:09 PM

Very impressed with the #OncosSec trial results. $ONCS $MRK $BMY

1 to 4 of 4 comments